- Profile
- prev
- next
General
-
Headquarters
Hong Kong
-
Founders & Team
Alex Zhavoronkov
-
Year Founded
2014
-
Number of employees
4
-
Company type
Private company
-
Funding stage
Series B
-
Total funding ($M)
51.3
Technical Details
-
Product modality
artificial intellegence for small molecule leads
About
Our Mission is to accelerate drug discovery and drug development by continuously inventing and deploying new artificial intelligence technologies.
We provide artificial intelligence solutions to the top industry players and use these solutions internally to develop a pipeline of therapeutic programs in cancer, fibrosis, antiinfectives, immunology, and senescence
We aspire to be a leader in the field of deep learning for drug discovery and development by relentlessly innovating, publishing proofs of concept in peer-reviewed academic journals, and delivering great AI software for the top industry experts